CDP323
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Multiple Sclerosis | CDP323 Biomarker Study | Phase 2 |
C32325
Completed |
NCT00726648 | "Wolf et al. PLoS ONE;2013;8;3;e58438. " | ||
| Multiple Sclerosis | Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 | Phase 2 |
C32322
Terminated |
NCT00484536 2006-002204-33 |
LINK
|
Polman, C. et al. Neurology;3-2-2010;74;9 Suppl. 2;A293 62nd Annual Meeting of the American Academy of Neurology (AAN), April 10-17, 2010;Toronto, Canada |